ArticleCureus2024
Knowledge and Perception of Anti-obesity Medications Among Primary Healthcare Center Visitors in Jeddah, Saudi Arabia in 2024: An Analytical Cross-Sectional Study.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Quality of life for post gastric sleeve surgery patients: a cross sectional study.BMC surgery · 2026Article
- Prevalence and Factors Associated with GLP-1 Receptor Agonist Use for Weight Management Among Overweight and Obese Adults in the Eastern Province of Saudi Arabia.Healthcare (Basel, Switzerland) · 2026Article
- Clinical studies on anti-obesity medications in Arab countries.Saudi medical journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is a significant public health concern globally, with an alarming prevalence in Saudi Arabia. While anti-obesity medications (AOMs) offer a pharmacological approach to weight management, their awareness and perception remain underexplored.
objectiveTo assess the knowledge, perception, and prevalence of AOM usage among primary healthcare visitors in Jeddah, Saudi Arabia.
methodsA cross-sectional study was conducted among 361 primary healthcare visitors aged 18 to 60 in Jeddah. Data on demographics, knowledge, and usage of AOMs were collected using a structured online questionnaire. The study employed a multistage sampling technique to ensure a representative sample. Statistical analyses included median and interquartile ranges (IQR) for continuous variables and frequencies and proportions for categorical variables. Knowledge differences were assessed using the Mann-Whitney U test and the Kruskal-Wallis test. A pilot study with 10% of the sample was conducted to refine the questionnaire. Approval from the Ethics Committee was obtained, and participants provided informed consent.
resultsThe study found a median knowledge score of 44.4% regarding AOMs. Significant associations were noted between higher knowledge levels and educational attainment (p=0.008), healthcare worker status (p=0.009), monthly income (p=0.029), and previous use of weight loss medications (p<0.001). The most commonly used AOM was Ozempic (13.0%). Social media emerged as the most common source of information, positively correlating with higher knowledge levels (p=0.006). Additionally, 72.0% of participants were aware that not everyone is suitable for AOMs, and 78.9% understood that these medications are more effective when combined with diet and exercise. Side effects awareness varied, with 32.1% recognizing nausea and vomiting and 55.4% aware of the increased risks of pancreatitis.
conclusionThe study reveals that primary healthcare visitors in Jeddah have a moderate level of knowledge about AOMs, with significant differences based on education, professional status, and sources of information. To improve awareness and appropriate use of AOMs, targeted educational interventions should be implemented. These interventions could help reduce obesity-related health issues by ensuring that individuals are well-informed about the benefits and risks of AOMs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.